Sirion Therapeutics   Report issue

Contributed to NME For profit Phase 2 Phase 3
Founded: Martinsried Germany (2007)
Status: Acquired by Perkin Elmer Inc. (2021)

Organization Overview

First Clinical Trial
2007
NCT00407225
First Marketed Drug
2008
difluprednate (durezol)
First NDA Approval
2008
difluprednate (durezol)
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree